References:
1. Ruda R, Soffietti R. What is New in the Management of Epilepsy in
Gliomas? Curr Treat Options Neurol. 2015;17(6):351.
2. Mulcahy Levy JM, McMahon M. Linking brain tumors and epileptic
seizures. Nature Medicine. 2018;24(11):1638-9.
3. Holthausen H, Blumcke I. Epilepsy-associated tumours: what
epileptologists should know about neuropathology, terminology, and
classification systems. Epileptic Disord. 2016;18(3):240-51.
4. Luzzi S, Elia A, Del Maestro M, Elbabaa SK, Carnevale S, Guerrini F,
et al. Dysembryoplastic Neuroepithelial Tumors: What You Need to Know.
World Neurosurg. 2019;127:255-65.
5. Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M,
Krishnatry R, et al. Therapeutic and Prognostic Implications of BRAF
V600E in Pediatric Low-Grade Gliomas. J Clin Oncol. 2017;35(25):2934-41.
6. Phi JH, Kim SK. Clinical Pearls and Advances in Molecular Researches
of Epilepsy-Associated Tumors. J Korean Neurosurg Soc.
2019;62(3):313-20.
7. Blumcke I, Budday S, Poduri A, Lal D, Kobow K, Baulac S. Neocortical
development and epilepsy: insights from focal cortical dysplasia and
brain tumours. The Lancet Neurology. 2021;20(11):943-55.
8. Luyken C, Blumcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, et
al. The spectrum of long-term epilepsy-associated tumors: long-term
seizure and tumor outcome and neurosurgical aspects. Epilepsia.
2003;44(6):822-30.
9. Huberfeld G, Vecht CJ. Seizures and gliomas–towards a single
therapeutic approach. Nat Rev Neurol. 2016;12(4):204-16.
10. Battaglia DI, Gambardella ML, Veltri S, Contaldo I, Chillemi G,
Veredice C, et al. Epilepsy and BRAF Mutations: Phenotypes, Natural
History and Genotype-Phenotype Correlations. Genes (Basel). 2021;12(9).
11. Slegers RJ, Blumcke I. Low-grade developmental and epilepsy
associated brain tumors: a critical update 2020. Acta Neuropathol
Commun. 2020;8(1):27.
12. Stone TJ, Rowell R, Jayasekera BAP, Cunningham MO, Jacques TS.
Review: Molecular characteristics of long-term epilepsy-associated
tumours (LEATs) and mechanisms for tumour-related epilepsy (TRE).
Neuropathol Appl Neurobiol. 2018;44(1):56-69.
13. Xing H, Song Y, Zhang Z, Koch PD. Clinical Characteristics of BRAF
V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a
Meta-analysis. J Mol Neurosci. 2021;71(9):1815-24.
14. Marucci G, de Biase D, Visani M, Giulioni M, Martinoni M, Volpi L,
et al. Mutant BRAF in low-grade epilepsy-associated tumors and focal
cortical dysplasia. Ann Clin Transl Neurol. 2014;1(2):130-4.
15. Perez JPM, Muchart J, Lopez VS, Capella MS, Salvador N, Jaume SP, et
al. Targeted therapy for pediatric low-grade glioma. Childs Nerv Syst.
2021.
16. Koh HY, Kim SH, Jang J, Kim H, Han S, Lim JS, et al. BRAF somatic
mutation contributes to intrinsic epileptogenicity in pediatric brain
tumors. Nat Med. 2018;24(11):1662-8.